Search - tctmd.com

Displaying 21 - 31 of 31

Sort: Relevancy | Date

Take Heed of Sex Differences in Peripheral Vascular Disease: AHA

News Daily News

Take Heed of Sex Differences in Peripheral Vascular Disease: AHA

Michael O'Riordan

March 13, 2025

ACC/AHA Release New Comprehensive ACS Guidelines

News Daily News

ACC/AHA Release New Comprehensive ACS Guidelines

February 27, 2025

AHA Scientific Statement Takes Aim at PAD Pain

News Daily News

AHA Scientific Statement Takes Aim at PAD Pain

February 13, 2025

US Football Fans Are Flooded With Ads for Unhealthy Foods

News Daily News

US Football Fans Are Flooded With Ads for Unhealthy Foods

Michael O'Riordan

January 30, 2025

AHA Stats Show CV Health of Americans Remains Dire

News Daily News

AHA Stats Show CV Health of Americans Remains Dire

Michael O'Riordan

January 28, 2025

Aspirin Use for Primary Prevention Declining in US: NHANES

News Daily News

Aspirin Use for Primary Prevention Declining in US: NHANES

Michael O'Riordan

January 24, 2025

Surgeons Formalize Support for ESC’s Stance on Revascularization in CCS

News Daily News

Surgeons Formalize Support for ESC’s Stance on CCS Revascularization

Michael O'Riordan

January 20, 2025

CV and Stroke Nursing Challenges Addressed in AHA Scientific Statement

News Daily News

CV and Stroke Nursing Challenges Addressed in AHA Scientific Statement

January 02, 2025

Presentation AHA 2024

Comparison of Linear Ablation Plus Pulmonary Vein Isolation Versus Pulmonary Vein Isolation Alone for Persistent Atrial Fibrillation

Presenter: Chenyang Jiang

November 18, 2024

Presentation AHA 2024

Routine spironolactone in Acute Myocardial Infarction, results from the CLEAR SYNERGY OASIS 9 trial

Presenter: Sanjit S Jolly

November 17, 2024

AZALEA-TIMI 71: Abelacimab Slashes Bleeds vs Rivaroxaban in AF, but Stroke Impact Unclear

News Conference News AHA 2023

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

November 12, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.